comparemela.com

Latest Breaking News On - Tasly biopharmaceuticals co ltd - Page 1 : comparemela.com

Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China

STRO-002 is a FolRα-targeting antibody-drug conjugate (ADC), currently in clinical studies for patients with ovarian and endometrial cancers in the U.S. and Europe.

Hong kongUnited kingdomSutro biopharmaAnniej changSutro xpressKaijing yanTasly biopharmaceuticals co ltdBionova pharmaceuticalsCelgene corporationExchange commissionTasly pharmaceutical group co ltdMerck kgaSutro biopharma incMerck kgaaBristol myers squibbGreater china

STRO stock: Why Sutro Biopharma Gained Further Pre-Market?

Sutro Biopharma Inc. (STRO) stock advanced further in the pre-market on news of an exclusive license agreement with Tasly.

Hong kongTasly pharmaceuticals group co ltdTasly biopharmaceuticals co ltdSutro biopharma incSutro biopharmaGreater china

Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive License Agreement for STRO-002 in Greater China

/PRNewswire/ Sutro Biopharma, Inc. ("Sutro") (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the.

Hong kongUnited kingdomSutro biopharmaAnniej changSutro xpressKaijing yanTasly biopharmaceuticals co ltdBionova pharmaceuticalsCelgene corporationExchange commissionTasly pharmaceutical group co ltdMerck kgaSutro biopharma incMerck kgaaBristol myers squibbGreater china

vimarsana © 2020. All Rights Reserved.